Table 4.
Survey of Reported Structures of Naturally Occurring 5,7-Diamino-3,5,7,9-tetradeoxynon-2-ulosonic Acid Derivatives, and Some Related Structures, Which Are Terminal or Internal Units of Bacterial Homo- and Hetero-polysaccharides and Glycoprotein Glycans595, 677, 679, 681
| Name | Abbreviation | References |
|---|---|---|
| *5,7-Diamino-3,5,7,9-tetradeoxy-l-glycero-l-manno-non-2-ulosonic acid/pseudaminic acid (Pse) | ||
| 5,7-Di-N-acetyl-pseudaminic acid | Pse5,7Ac2 | 688, 689 |
| 5,7-Di-N-acetyl-8-O-acetyl-pseudaminic acid | Pse5,7,8Ac3 | 689 |
| 5,7-Di-N-acetyl-8-O-glycyl-pseudaminic acid | Pse5,7Ac28Gly | 690 |
| 5,7-Di-N-glyceryl-pseudaminic acid | Pse5,7Gr2 | 689 |
| 5-N-Acetimidoyl-7-N-acetyl-pseudaminic acid | Pse7Ac5Am | 689, 691 |
| 5-N-Acetimidoyl-7-N-acetyl-8-O-acetyl-pseudaminic acid | Pse7,8Ac25Am | 692 |
| 5-N-Acetimidoyl-7-N-acetyl-8-O-(N-acetyl-glutaminyl)-pseudaminic acid | Pse7Ac5Am8GlnNAc | 690 |
| 5-N-Acetyl-7-N-formyl-pseudaminic acid | Pse5Ac7Fo | 682, 693 |
| 5-N-Acetyl-7-N-l-glyceryl-pseudaminic acid | Pse5Ac7Gr | 694 |
| 5-N-Acetyl-7-N-[(R)-3-hydroxybutyryl]-pseudaminic acid | Pse5Ac7(3RHb) | 682, 695, 696 |
| 5-N-Acetyl-7-N-[(R)-3-hydroxybutyryl]-4-O-acetyl-pseudaminic acid | Pse4,5Ac27(3RHb) | 697 |
| 5-N-Acetyl-7-N-[(S)-3-hydroxybutyryl]-pseudaminic acid | Pse5Ac7(3SHb) | 696 |
| 5-N-Acetyl-7-N-(4-hydroxybutyryl)-pseudaminic acid | Pse5Ac7(4Hb) | 698 |
| 5-N-Acetyl-7-N-(3,4-dihydroxybutyryl)-pseudaminic acid | Pse5Ac7(3,4Hb) | 602 |
| 7-N-Acetimidoyl-5-N-acetyl-pseudaminic acid | Pse5Ac7Am | 699 |
| 7-N-Acetimidoyl-5-N-(2,3-di-O-methyl-glyceryl)-pseudaminic acid | Pse7Am5Me2Gr | 700 |
| 7-N-Acetyl-5-N-(3-hydroxybutyryl)-pseudaminic acid | Pse7Ac5(3Hb) | 701 |
| 7-N-Acetyl-5-N-(2,3-di-O-methyl-glyceryl)-pseudaminic acid | Pse7Ac5Me2Gr | 700 |
| 7-N-Formyl-5-N-[(R)-3-hydroxybutyryl]-pseudaminic acid | Pse7Fo5(3RHb) | 682, 702, 703 |
| *5,7-Diamino-3,5,7,9-tetradeoxy-d-glycero-d-galacto-non-2-ulosonic acid/legionaminic acid (Leg) | ||
| 5,7-Di-N-acetyl-legionaminic acida | Leg5,7Ac2 | 684, 704, 705 |
| 5-N-Acetimidoyl-7-N-acetyl-legionaminic acida | Leg7Ac5Am | 684, 705 |
| 5-N-Acetimidoyl-7-N-acetyl-8-O-acetyl-legionaminic acidb | Leg7,8Ac25Am | 684, 706 |
| 5-N-Acetimidoyl-7-N-acetyl-5-N-methyl-legionaminic acid | Leg7Ac5Am5Me | 707 |
| 5-N-(N-Methyl-acetimidoyl)-7-N-acetyl-legionaminic acid | Leg7Ac5AmMe | 705, 707 |
| 5-N-(N,N-Dimethyl-acetimidoyl)-7-N-acetyl-legionaminic acid | Leg7Ac5AmMe2 | 707 |
| 5-N-Acetimidoyl-7-N-acetyl-8-O-acetyl-5-N-methyl-legionaminic acid | Leg7,8Ac25Am5Me | 706 |
| 5-N-(N,N-Dimethyl-acetimidoyl)-7-N-acetyl-8-O-acetyl-legionaminic acid | Leg7,8Ac25AmMe2 | 706 |
| 5-N-Acetyl-7-N-(N-acetyl-d-alanyl)-legionaminic acid | Leg5Ac7AlaNAc | 704 |
| 5-N-Acetyl-7-N-(d-alanyl)-legionaminic acid | Leg5Ac7Ala | 708 |
| 7-N-Acetyl-5-N-formyl-legionaminic acid | Leg7Ac5Fo | 709 |
| 7-N-Acetyl-5-N-[(S)-3-hydroxybutyryl]-legionaminic acidc | Leg7Ac5(3SHb) | 684 |
| 7-N-Acetyl-5-N-(N-methyl-5-glutamyl)-legionaminic acid | Leg7Ac5GluNMe | 710 |
| *5,7-Diamino-3,5,7,9-tetradeoxy-d-glycero-d-talo-non-2-ulosonic acid/4-epi-legionaminic acid (4eLeg) | ||
| 5,7-Di-N-acetyl-4-epi-legionaminic acid | 4eLeg5,7Ac2 | 711 |
| 5,7-Di-N-acetyl-8-O-acetyl-4-epi-legionaminic acidd | 4eLeg5,7,8Ac3 | 684 |
| 5-N-Acetimidoyl-7-N-acetyl-4-epi-legionaminic acid | 4eLeg7Ac5Am | 712 |
| 5-N-Acetimidoyl-7-N-acetyl-8-O-acetyl-4-epi-legionaminic acid | 4eLeg7,8Ac25Am | 712 |
| *5,7-Diamino-3,5,7,9-tetradeoxy-l-glycero-d-galacto-non-2-ulosonic acid/8-epi-legionaminic acid (8eLeg) | ||
| 5,7-Di-N-acetyl-8-epi-legionaminic acide | 8eLeg5,7Ac2 | 713, 714, 715 |
| 5,7-Di-N-acetyl-8-O-acetyl-8-epi-legionaminic acid | 8eLeg5,7,8Ac3 | 716 |
| 5-N-Acetimidoyl-7-N-acetyl-8-epi-legionaminic acid | 8eLeg7Ac5Am | 717 |
| 7-N-Acetimidoyl-5-N-acetyl-8-epi-legionaminic acid | 8eLeg5Ac7Am | 79 |
| 7-N-Acetimidoyl-5-N-acetyl-8-O-acetyl-8-epi-legionaminic acid | 8eLeg5,8Ac27Am | 79 |
| 7-N-Acetyl-5-N-[(R)-3-hydroxybutyryl]-8-epi-legionaminic acide | 8eLeg7Ac5(3RHb) | 684, 713, 714 |
| 7-N-Acetyl-5-N-(4-hydroxybutyryl)-8-epi-legionaminic acide | 8eLeg7Ac5(4Hb) | 684 |
| *5,7-Diamino-3,5,7,9-tetradeoxy-l-glycero-l-altro-non-2-ulosonic acid/acinetaminic acid (Aci) | ||
| 5,7-Di-N-acetyl-acinetaminic acid | Aci5,7Ac2 | 686 |
| *5,7-Diamino-3,5,7,9-tetradeoxy-d-glycero-l-altro-non-2-ulosonic acid/8-epi-acinetaminic acid (8eAci) | ||
| 5,7-Di-N-acetyl-8-epi-acinetaminic acid | 8eAci5,7Ac2 | 687 |
| *Some related 9-deoxynon-2-ulosonic acids | |
| 5- or 7-Acetamido-,7- or 5-(3-hydroxybutyramido)-5,7,9-trideoxynon-2-ulosonic acid | 718 |
| 5-Acetamido-7-[(S)-3-hydroxybutyramido]-8-amino-3,5,7,8,9-pentadeoxy-l-glycero-l-manno- or d-glycero-l-manno-non-2-ulosonic acid | 719 |
| 5-Acetamidino-3,5,9-trideoxy-l-glycero-l-gluco-non-2-ulosonic acid (tentatively assigned chirality; trivial name: fusaminic acid) | 720 |
| 5,7-Diacetamido-8-amino-3,5,7,8,9-pentadeoxy-d-glycero-d-galacto-non-2-ulosonic acid | 721 |
Included literature refers to first reports or revised reports.
a
Initially assigned with the d-glycero-l-galacto722 and later with the l-glycero-d-galacto713, 714, 723 configuration.
b
Initially assigned with the d-glycero-l-galacto,724, 725, 726 and later with the l-glycero-d-galacto713, 714 configuration.
c
Initially assigned with the l-glycero-d-galacto configuration.723
d
Initially assigned with the l-glycero-d-talo configuration.727